STEINMAN LAWRENCE - Insider Non-Derivative Transactions at Pasithea Therapeutics Corp. (KTTA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 2, 2023, STEINMAN LAWRENCE's relationship to Pasithea Therapeutics Corp. (KTTA) is Director, and currently has 1,327,174 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other KTTA insiders.
Data Source: SEC.
STEINMAN LAWRENCE - Insider Non-Derivative Transactions at KTTA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 3, 2023 | P -- (Common Stock) | 30000 | 0.43 | 1327174 |